Physician profile
Ashutosh Kaul
NPI 1760484265
$11,830.82
in general payments reported to CMS, 2019-2025
20 companies · $552 in 2025
The $552 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,889 · 2020: $159 · 2021: $5,202 · 2022: $877 · 2023: $500 · 2024: $2,651 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,959 · Travel and Lodging: $735 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,959.03 |
| Travel and Lodging | $735.42 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,473.73 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $4,304.55 | 2021-2025 | Phasix Mesh |
| Novo Nordisk INC | $523.26 | 2019-2025 | Wegovy, Saxenda, Rybelsus |
| Medtronic, INC. | $426.07 | 2022-2025 | Ligasure |
| Stryker Corporation | $326.14 | 2022 | |
| Allergan, INC. | $322.18 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $277.51 | 2019-2025 | Gore Tag Conformable Thoracic Stent Graft, Gore Tag Thoracic Branch Endoprosthesis, Gore Enform Preperitoneal Biomaterial |
| Abbvie INC. | $246.15 | 2023-2024 | |
| Covidien LP | $171.16 | 2019 | |
| Ethicon US, LLC | $159.85 | 2019 | |
| Dilon Technologies, INC. | $146.60 | 2024 | Hemoblast Bellows |
| Apollo Endosurgery US INC | $120.00 | 2022 | |
| Ironwood Pharmaceuticals, INC | $107.34 | 2019 | |
| Cook Medical LLC | $95.52 | 2024 | Zenith Spiral-Z |
| Currax Pharmaceuticals LLC | $41.51 | 2021-2023 | Contrave, Onzetra Xsail |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $23.53 | 2022 | |
| Teleflex LLC | $22.25 | 2024 | Titan Sgs |
| Heron Therapeutics, INC. | $15.19 | 2022 | |
| Olympus America INC. | $14.50 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $13.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashutosh Kaul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.